Table 3 Analyses of risk for benign paroxysmal positional vertigo in patients with and without anxiety disorders

Anxiety disorders

2.52 (1.92–3.32)

<.001

2.17 (1.63–2.90)

<.001

Age (≥60 = 1, <60 = 0)

1.44 (1.08–1.92)

.014

1.09 (0.78–1.53)

.601

Sex (female = 1, male = 0)

1.60 (1.23–2.10)

.001

1.65 (1.26–2.17)

<.001

 Hypertension

1.76 (1.34–2.32)

<.001

1.06 (0.75–1.48)

.751

 Diabetes mellitus

1.93 (1.18–3.15)

.009

1.18 (0.70–1.99)

.528

 Chronic liver diseases

1.48 (1.12–1.96)

.006

0.95 (0.70–1.29)

.719

 Autoimmune diseases

1.28 (0.80–2.04)

.309

 Congestive heart failure

1.95 (1.04–3.67)

.039

1.02 (0.52–1.98)

.958

 Hyperlipidemia

2.06 (1.53–2.76)

<.001

1.36 (0.96–1.92)

.084

 Nephropathy

2.46 (1.72–3.54)

<.001

1.69 (1.14–2.48)

.008

 Cerebrovascular disease

2.33 (1.64–3.32)

<.001

1.51 (1.02–2.24)

.039

 COPD

1.87 (1.40–2.49)

<.001

1.35 (0.99–1.84)

.055